Evaluation of cyclophosphamide for steroid-refractory hepatic acute graft-vs-host disease after allogeneic hematopoietic stem cell transplantation
These findings suggest that CTX is a promising and well-tolerated treatment option for patients with SR-hepatic aGVHD.
Authors
- Xiao‐Hui Zheng (ORCID: https://orcid.org/0000-0002-5128-6649)
- S. feng
- Erlie Jiang (ORCID: https://orcid.org/0000-0003-0237-6063)
- J J Wei
- Yigeng Cao
- Ni Lu (ORCID: https://orcid.org/0009-0002-2721-9224)
- Dan Feng (ORCID: https://orcid.org/0009-0001-6300-9980)
- Weihua Zhai
- Yawei Zheng
- Mingzhe Han
- Donglin Yang
- Rongli Zhang
- Wenwen Guo
- Aiming Pang
- Yi He
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- National Clinical Research (US)
- Institute of Hematology & Blood Diseases Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-03-02
- DOI
- https://doi.org/10.3389/fimmu.2026.1678723
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Tianjin City
- National Science and Technology Major Project